GT Biopharma is trading at $5.00, down 5.12%, with no identified company-specific announcement explaining the decline.
- The price was recorded as of 11:14 a.m. EST on November 4, 2026.
- The latest identified company news was an October 26 announcement about a planned oral presentation at the November SITC meeting.
- Biotech and major U.S. indexes were higher; current trading volume was not verified.